98 results
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:42am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:41am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:39am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
8-K
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
with the consummation of the Merger and effective as of the Effective Time, the Company terminated the POINT Biopharma Global Inc. 2020 Equity Incentive … Plan and the POINT Biopharma Global Inc. 2021 Equity Incentive Plan.
Item 2.01 Completion of Acquisition or Disposition of Assets.
The disclosures
SC 14D9
br065os6eau9mtaj14
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
pd99xh
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.2
os3 dtant49g
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-2.1
glvr32r4oda0y1 en2v
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
6himoq dkh6pky
3 Oct 23
Tender and Support Agreement
7:35am
S-8
EX-5.1
2qgptkdhj 5y18wv
14 Aug 23
Registration of securities for employees
10:22am
S-8
yfi6wd
14 Aug 23
Registration of securities for employees
10:22am
S-8
z5p9vw wz4
14 Aug 23
Registration of securities for employees
10:22am
ARS
8z263s32g5js7t
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
ffr2o2cpkcafr1jad
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm